{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:43:26Z","timestamp":1778327006044,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.biopha.2020.110816","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T02:50:22Z","timestamp":1602298222000},"page":"110816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies"],"prefix":"10.1016","volume":"132","author":[{"given":"Ching-Yuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hsin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ching","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung Te","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2020.110816_bib0005","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2020.110816_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.11.032","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2020.110816_bib0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.110816_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2020.110816_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2020.110816_bib0030","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","author":"Baig","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2020.110816_bib0035","doi-asserted-by":"crossref","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","author":"Zou","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2020.110816_bib0040","article-title":"Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19\/SARS-CoV-2","author":"Li","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2020.110816_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110195","article-title":"New understanding of the damage of SARS-CoV-2 infection outside the respiratory system","volume":"127","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2020.110816_bib0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jcph.1641","article-title":"TMPRSS2: Potential Biomarker for COVID-19 Outcomes","volume":"60","author":"Strope","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110816_bib0055","doi-asserted-by":"crossref","DOI":"10.1111\/all.14429","article-title":"Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors","author":"Radzikowska","year":"2020","journal-title":"Allergy"},{"issue":"10234","key":"10.1016\/j.biopha.2020.110816_bib0060","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2020.110816_bib0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.110816_bib0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.110816_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.biopha.2020.110816_bib0080","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.biopha.2020.110816_bib0085","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the COVID-19 pandemic: At present there is No evidence to abandon renin-angiotensin system blockers","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.110816_bib0090","doi-asserted-by":"crossref","DOI":"10.2174\/1568026620666200710105507","article-title":"Therapeutic targets and computational approaches on drug development for COVID-19","author":"Shanmugam","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2020.110816_bib0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jep.2017.08.011","article-title":"Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway","volume":"209","author":"Lin","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110816_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40360-018-0195-4","article-title":"Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway","volume":"19","author":"Lee","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2020.110816_bib0105","article-title":"Ginsenoside Rg3 attenuates angiotensin II-Mediated renal injury in rats and mice by upregulating angiotensin-converting enzyme 2 in the renal tissue","volume":"2019","author":"Liu","year":"2019","journal-title":"Evid. Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.biopha.2020.110816_bib0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"16","key":"10.1016\/j.biopha.2020.110816_bib0115","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1128\/JVI.00253-07","article-title":"Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted","volume":"81","author":"Inoue","year":"2007","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110816_bib0120","first-page":"631","article-title":"H. Van Goor, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus","volume":"203","author":"Hamming","year":"2004","journal-title":"A first step in understanding SARS pathogenesis, J Pathol"},{"key":"10.1016\/j.biopha.2020.110816_bib0125","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"issue":"6965","key":"10.1016\/j.biopha.2020.110816_bib0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2020.110816_bib0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41585-020-0319-7","article-title":"The need for urogenital tract monitoring in COVID-19","volume":"17","author":"Wang","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110816_bib0140","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00134-020-06153-9","article-title":"Acute kidney injury in critically ill patients with COVID-19","volume":"46","author":"Gabarre","year":"2020","journal-title":"Intensive Care Med."},{"issue":"23","key":"10.1016\/j.biopha.2020.110816_bib0145","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110816_bib0150","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.biopha.2020.110816_bib0155","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.110816_bib0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fmed.2020.00248","article-title":"The lung, the heart, the novel coronavirus, and the renin-angiotensin system; the need for clinical trials","volume":"7","author":"Lumbers","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"issue":"10","key":"10.1016\/j.biopha.2020.110816_bib0165","doi-asserted-by":"crossref","DOI":"10.15252\/embj.20105114","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.biopha.2020.110816_bib0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17103433","article-title":"The expression and polymorphism of entry machinery for COVID-19 in human: juxtaposing population groups, gender, and different tissues","volume":"17","author":"Darbani","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.biopha.2020.110816_bib0175","first-page":"1","article-title":"Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"10.1016\/j.biopha.2020.110816_bib0180","article-title":"Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells","volume":"9","author":"Senthil Kumar","year":"2020","journal-title":"Plants Basel (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2020.110816_bib0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7774\/cevr.2018.7.1.37","article-title":"Anti-infective potential of catechins and their derivatives against viral hepatitis","volume":"7","author":"Song","year":"2018","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110816_bib0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1871528114666151022150122","article-title":"Compounds derived from Epigallocatechin-3-Gallate (EGCG) as a novel approach to the prevention of viral infections","volume":"14","author":"Hsu","year":"2015","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.biopha.2020.110816_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25761","article-title":"The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase","author":"Lung","year":"2020","journal-title":"J. Med. Virol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222031009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222031009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:59:16Z","timestamp":1760097556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222031009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":39,"alternative-id":["S075333222031009X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110816","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110816"}}